We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 4,430 results
  1. The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer

    Cervical cancer is one of the most common female malignancies. Human papillomaviruses (HPV) are the main causative agents of virtually all cervical...

    Yi Liu, Hejing Liu, ... Xueqiong Zhu in Apoptosis
    Article 18 August 2022
  2. Interaction of miR-200a-3p with YAP regulates cell proliferation and metastasis differentially in HPV-positive and HPV-negative cervical cancer cells

    Background

    Although evidence has revealed that miR-200a-3p is involved in the malignant progression of various tumors, the regulatory mechanism of...

    Hong Chen, Lingling Gu, ... Jun Zhang in BMC Cancer
    Article Open access 04 October 2022
  3. HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women

    Background

    In populations with high rates of human immunodeficiency virus (HIV)-coinfection, the nature of the relationship between human...

    Mwiza Gideon Singini, Elvira Singh, ... Freddy Sitas in Infectious Agents and Cancer
    Article Open access 29 March 2022
  4. Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer

    Background

    The prognostic significance of tumour budding (TB) and minimal cell nest size (MCNS) was shown in human papillomavirus (HPV)-negative head...

    Fabian Stögbauer, Susanne Beck, ... Jan Budczies in British Journal of Cancer
    Article Open access 12 April 2023
  5. Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly women

    Purpose

    Cervical cancer prevention for older women can be challenging since there are no specific guidelines for this group . This study aimed to...

    Ruth S. Hermansson, Matts Olovsson, ... Annika K. Lindström in Infectious Agents and Cancer
    Article Open access 03 August 2022
  6. Synbiotics in Cervical Cancer

    The gut microbiota is usually regarded as one of the most crucial aspects in maintaining homeostasis. Probiotic microbes have been proven to come up...
    Sumel Ashique, Ashish Garg, ... Neeraj Mishra in Synbiotics for the Management of Cancer
    Chapter 2023
  7. HPV16-miRNAs exert oncogenic effects through enhancers in human cervical cancer

    Background

    Cervical cancer is a human papillomavirus (HPV)-related disease. HPV type 16 (HPV16), which is the predominant cause of cervical cancer,...

    Yunuan Wang, Xueying Wang, ... Qi Lu in Cancer Cell International
    Article Open access 15 May 2024
  8. Biosimilar in Cervical Cancer

    Cervical Cancer is a serious health concern possessing a serious health problem in women. This chapter provides a comprehensive overview of the role...
    Saurabh Morparia, Vasanti Suvarna, Manikanta Murahari in Biosimilars for Cancer Treatment
    Chapter 2024
  9. Immunotherapy for Cervical Cancer

    Cervical cancer is a highly prevalent gynecological malignancy worldwide, and it is associated with high-risk human papillomavirus (HPV) infection....
    Adriana Gutiérrez-Hoya, Arturo Valle-Mendiola, Isabel Soto-Cruz in Handbook of Cancer and Immunology
    Living reference work entry 2023
  10. Clinical evaluation of an artificial intelligence-assisted cytological system among screening strategies for a cervical cancer high-risk population

    Background

    Primary cervical cancer screening and treating precancerous lesions are effective ways to prevent cervical cancer. However, the coverage...

    Wen Yang, Xiangshu Jin, ... Yuanguang Meng in BMC Cancer
    Article Open access 27 June 2024
  11. Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria

    Background

    High risk human papillomaviruses (HR-HPV) have a causal role in cervical oncogenesis, and HIV-mediated immune suppression allows HR-HPV to...

    Jonah Musa, Mamoudou Maiga, ... Supriya Dinesh Mehta in BMC Cancer
    Article Open access 20 July 2023
  12. High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting

    Background

    For women living with HIV (WLHIV), the burden of persistent HPV infection, cervical pre-cancerous lesions and cancer have been demonstrated...

    Patrick Kafui Akakpo, Sebastian Ken-Amoah, ... Dorcas Obiri-Yeboah in Infectious Agents and Cancer
    Article Open access 26 May 2023
  13. A portable thermal ablation device for cervical cancer prevention in a screen-and-treat setting: a randomized, noninferiority trial

    Implementing standard-of-care cryotherapy or electrosurgical excision to treat cervical precancers is challenging in resource-limited settings. An...

    Partha Basu, Mulindi Mwanahamuntu, ... Groesbeck P. Parham in Nature Medicine
    Article Open access 25 June 2024
  14. Hepatitis B or C viral infection and the risk of cervical cancer

    Background

    The present study aimed to evaluate the effects of hepatitis B virus (HBV) or hepatitis C virus (HCV) infection on the risk of cervical...

    Chuanfang Luo, Shuhui Yu, ... Lan Zhang in Infectious Agents and Cancer
    Article Open access 01 November 2022
  15. Possible role of negative human papillomavirus E6/E7 mRNA as a predictor of regression of cervical intraepithelial neoplasia 2 lesions in hr-HPV positive women

    Background

    The aim of this study was to evaluate the regression rate of CIN2 p16 positive lesions in women over 25 years of age and identify possible...

    Maria Teresa Bruno, Nazario Cassaro, ... Sara Boemi in Virology Journal
    Article Open access 27 May 2022
  16. DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test

    Background

    Cervical screening using primary human papilloma virus (HPV) testing and cytology is being implemented in several countries. Cytology as...

    Chiara Herzog, Karin Sundström, ... Martin Widschwendter in Clinical Epigenetics
    Article Open access 21 November 2022
  17. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer

    Background

    Cervical screening is transitioning from primary cytology to primary human papillomavirus (HPV) testing. HPV testing is highly sensitive...

    James E. Barrett, Karin Sundström, ... Martin Widschwendter in Genome Medicine
    Article Open access 19 October 2022
  18. Understanding the Role of Synbiotics in Prevention and Management of Cervical Cancer

    Cervical cancer appeared to be the fourth most common cancer among women worldwide and Human Papillomavirus (HPV) is identified as the primary causal...
    Anindita Goswami, Suvanjana Ghosh, ... Paramita Mandal in Synbiotics for the Management of Cancer
    Chapter 2023
  19. Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial

    Objective

    This study aims to evaluate the feasibility and applicability of an online cervical cancer screening program using a website as the public...

    Yi Zhang, Hui Du, ... Ruifang Wu in Infectious Agents and Cancer
    Article Open access 25 April 2024
  20. Post-conization surveillance in an organized cervical screening program with more than 23,000 years of follow-up

    Background

    Cervical cancer is preventable through screening and vaccination against high-risk human papillomavirus (hr-HPV). For a screening program...

    Avalon Sundqvist, Johanna Nicklasson, ... Christer Borgfeldt in Infectious Agents and Cancer
    Article Open access 06 December 2023
Did you find what you were looking for? Share feedback.